Today, more than 70% of our patients with a cancer diagnosis are 65 or older. This generous grant will enable Penn Medicine Princeton Health's new Geriatric Oncology Program to transform cancer treatment and supportive care for older adults.
The program will expand its research infrastructure to design and implement clinical trials; bring new treatments and care delivery models in partnership with Penn Medicine’s Abramson Cancer Center; and recruit multidisciplinary teams of professionals with an expertise in geriatrics. The program will be led by Ramy Sedhom, MD, a co-leader of the geriatric oncology service line across the Penn Medicine system, a faculty member at the Penn Center for Cancer Care Innovation, and a representative on the National Comprehensive Cancer Network Clinical Practice Guideline Committee for Older Adult Oncology.
Bristol Myers Squibb’s philanthropic programs span the globe, focusing on reducing health disparities by strengthening communities. We are honored they have chosen to support the Princeton Health community in this impactful way.
Bristol Myers Squibb is a member of the Princeton Medical Center Foundation’s Corporate Partners Program, which was designed to create a mutually beneficial partnership by offering a variety of opportunities to support Princeton Health.